The OssDsign Catalyst® Commitment warranty program represents our confidence in Catalyst, which is supported by published real-world outcomes data. OssDsign will provide replacement product to a qualifying surgical facility where a patient undergoes an on-label spinal fusion procedure using OssDsign Catalyst nanosynthetic™ bone graft substitute and subsequently does not develop bridging bone within a specified postoperative window.
The program is available now to hospitals and ambulatory surgery centers (ASCs) across the United States. Facilities must enroll and meet the program’s eligibility requirements and documentation standards to qualify for replacement product.
Full warranty terms, eligibility criteria, and onboarding details can be obtained from your regional OssDsign account manager.
This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.
Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.
